{
    "organizations": [],
    "uuid": "f889f422967bd2a2fc2a5cdfcb3179ed1e2a004c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-us-fda-says-permitted-marketing-of/brief-u-s-fda-says-permitted-marketing-of-first-blood-test-to-evaluate-mild-traumatic-brain-injury-or-concussion-in-adults-idUSFWN1Q41JV",
    "ord_in_thread": 0,
    "title": "BRIEF-U.S. FDA Says Permitted Marketing Of First Blood Test To Evaluate Mild Traumatic Brain Injury, Or Concussion, In Adults",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 14 (Reuters) - U.S. Food and Drug Administration:\n* U.S. FOOD AND DRUG ADMINISTRATION SAYS PERMITTED MARKETING OF THE FIRST BLOOD TEST TO EVALUATE MILD TRAUMATIC BRAIN INJURY, OR CONCUSSION, IN ADULTS\n* U.S. FDA SAYS IS PERMITTING MARKETING OF BRAIN TRAUMA INDICATOR TO BANYAN BIOMARKERS INC Source text for Eikon:\n ",
    "published": "2018-02-15T03:02:00.000+02:00",
    "crawled": "2018-02-14T21:44:59.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "food",
        "drug",
        "administration",
        "food",
        "drug",
        "administration",
        "say",
        "permitted",
        "marketing",
        "first",
        "blood",
        "test",
        "evaluate",
        "mild",
        "traumatic",
        "brain",
        "injury",
        "concussion",
        "adult",
        "fda",
        "say",
        "permitting",
        "marketing",
        "brain",
        "trauma",
        "indicator",
        "banyan",
        "biomarkers",
        "inc",
        "source",
        "text",
        "eikon"
    ]
}